KHDRBS1 upregulation and cytosolic localization are associated with poor prognosis [11] in renal cell carcinoma and breast cancer [8], while in other types of cancers nuclear localization and high KHDRBS1 expression are associated with tumour progression and poor prognosis [12]. This evidence concerns the gene KHDRBS1 and renal cell carcinoma.